These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 19890833)

  • 1. Relapsed or refractory nongastric marginal zone B-cell lymphoma: multicenter retrospective analysis of 92 cases.
    Oh SY; Kim WS; Kim SJ; Kim JS; Kim SH; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Kim JG; Yang DH; Kang HJ; Choi CW; Park J; Choi YJ; Kim HJ; Kwon JH; Suh C; Kim HJ
    Am J Hematol; 2009 Dec; 84(12):826-9. PubMed ID: 19890833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa.
    Lee JL; Kim MK; Lee KH; Hyun MS; Chung HS; Kim DS; Shin SO; Cho HS; Bae SH; Ryoo HM
    Ann Hematol; 2005 Jan; 84(1):13-8. PubMed ID: 15309523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study.
    Oh SY; Kim WS; Kim JS; Kim SJ; Kwon HC; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Lee GW; Choi CW; Park J; Suh C; Kim HJ
    Ann Hematol; 2010 Jun; 89(6):563-8. PubMed ID: 20024551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and prognostic factors in ocular adnexal lymphoma.
    Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
    Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma).
    Son SH; Choi BO; Kim GW; Yang SW; Hong YS; Choi IB; Kim YS
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):86-91. PubMed ID: 19632068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nongastric marginal zone B-cell lymphoma: analysis of 247 cases.
    Oh SY; Ryoo BY; Kim WS; Park YH; Kim K; Kim HJ; Kwon JM; Lee J; Ko YH; Ahn YC; Oh SJ; Lee SI; Kim HJ; Kwon HC; Bang SM; Kim JH; Park J; Lee SS; Kim HY; Park K
    Am J Hematol; 2007 Jun; 82(6):446-52. PubMed ID: 17266060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.
    Uno T; Isobe K; Shikama N; Nishikawa A; Oguchi M; Ueno N; Itami J; Ohnishi H; Mikata A; Ito H
    Cancer; 2003 Aug; 98(4):865-71. PubMed ID: 12910532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome.
    Tsang RW; Gospodarowicz MK; Pintilie M; Wells W; Hodgson DC; Sun A; Crump M; Patterson BJ
    J Clin Oncol; 2003 Nov; 21(22):4157-64. PubMed ID: 14615444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up.
    Raderer M; Streubel B; Woehrer S; Puespoek A; Jaeger U; Formanek M; Chott A
    Clin Cancer Res; 2005 May; 11(9):3349-52. PubMed ID: 15867234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodal marginal zone B-cell lymphoma: Analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphoma.
    Oh SY; Ryoo BY; Kim WS; Kim K; Lee J; Kim HJ; Kwon JM; Lee HR; Ko YH; Oh SJ; Park KW; Kim HJ; Kwon HC; Nam E; Kim JH; Park YH; Lee SS; Kim HY; Park K
    Ann Hematol; 2006 Nov; 85(11):781-6. PubMed ID: 16847665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination.
    Arcaini L; Burcheri S; Rossi A; Passamonti F; Paulli M; Boveri E; Brusamolino E; Orlandi E; Molteni A; Pulsoni A; Cox MC; Orsucci L; Fabbri A; Frezzato M; Voso MT; Zaja F; Montanari F; Pascutto C; Morra E; Cortelazzo S; Lazzarino M
    Oncologist; 2006 Mar; 11(3):285-91. PubMed ID: 16549813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal marginal zone B-cell lymphoma of MALT type: clinical manifestation and outcome of a rare disease.
    Oh SY; Kwon HC; Kim WS; Hwang IG; Park YH; Kim K; Ko YH; Ryoo BY; Kang HJ; Nam E; Lee JH; Kim JH; Kim HJ
    Eur J Haematol; 2007 Oct; 79(4):287-91. PubMed ID: 17692101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients.
    Cho EY; Han JJ; Ree HJ; Ko YH; Kang YK; Ahn HS; Ahn SD; Park CJ; Huh J
    Am J Hematol; 2003 Jun; 73(2):87-96. PubMed ID: 12749009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area: high rate of disease recurrence following local therapy.
    Wenzel C; Fiebiger W; Dieckmann K; Formanek M; Chott A; Raderer M
    Cancer; 2003 May; 97(9):2236-41. PubMed ID: 12712477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit.
    Ben Simon GJ; Cheung N; McKelvie P; Fox R; McNab AA
    Ophthalmology; 2006 Jul; 113(7):1209-13. PubMed ID: 16647129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nongastric marginal zone B-cell lymphoma: a prognostic model from a retrospective multicenter study.
    Oh SY; Kwon HC; Kim WS; Park YH; Kim K; Kim HJ; Kwon JM; Lee J; Ko YH; Ahn YC; Oh SJ; Lee SI; Bang SM; Kim JH; Park J; Ryoo BY; Lee SS; Kim HY; Park K; Kim HJ
    Cancer Lett; 2007 Dec; 258(1):90-7. PubMed ID: 17936499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
    Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
    Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study.
    Oh SY; Kim WS; Kim JS; Kim SJ; Lee S; Lee DH; Kang HJ; Song MK; Kim HJ; Kwon JH; Kwak JY; Park BB; Do YR; Jeong SH; Suh C
    Acta Haematol; 2012; 127(2):100-4. PubMed ID: 22178776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lacrimal gland extranodal marginal zone B-cell lymphoma of MALT-type.
    Kao SC; Kau HC; Tsai CC; Tsay SH; Yang CF; Wu JS; Hsu WM
    Am J Ophthalmol; 2007 Feb; 143(2):311-316. PubMed ID: 17184716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy.
    Goda JS; Gospodarowicz M; Pintilie M; Wells W; Hodgson DC; Sun A; Crump M; Tsang RW
    Cancer; 2010 Aug; 116(16):3815-24. PubMed ID: 20564130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.